Flow Diagram of the Trial Selection Process

Jeffrey S. Berger et al, JAMA. 2006;295:306-313

Design of Trials Included in the Meta-analysis

Jeffrey S. Berger et al, JAMA. 2006;295:306-313

Characteristics of Men and Women Included in Trials of Aspirin for the Primary Prevention

of Cardiovascular Disease*

Jeffrey S. Berger et al, JAMA. 2006;295:306-313

Effect of Aspirin Treatment on the Primary Prevention of Major Cardiovascular Events and Myocardial Infarction

Jeffrey S. Berger et al, JAMA. 2006;295:306-313

Effect of Aspirin Treatment on the Primary Prevention of Stroke, Ischemic Stroke, and Hemorrhagic Stroke

Jeffrey S. Berger et al, JAMA. 2006;295:306-313

Effect of Aspirin Treatment on the Primary Prevention of Cardiovascular Mortality and Total Mortality

Jeffrey S. Berger et al, JAMA. 2006;295:306-313

Effect of Aspirin Treatment on Major Bleeding

Jeffrey S. Berger et al, JAMA. 2006;295:306-313